The global market for antiparasitic drugs market was estimated to be worth USD 24.4 billion in 2024, and a compound annual growth rate (CAGR) of 8.8% is anticipated over the course of the projected period. The market is expanding significantly because to the increased prevalence of parasitic infections, such as helminthiasis, malaria, and other neglected tropical diseases, which are mostly found in developing nations.

The market's need for antiparasitic medications is being driven by growing awareness of these illnesses and the necessity of an efficient treatment. The market is expanding at a substantial rate due to the trend toward bettering already available treatment alternatives. The market is expanding due to the rising number of malaria patients and the therapeutic development approach for the disease.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/antiparasitic-drugs-market

Growth Drivers

The market is expanding rapidly due to the growing need for antiparasitic medications to treat malaria effectively worldwide. North America is the most affected region; according to data from 2023, a kid dies from malaria every two to three minutes, and there are over 200 billion cases reported globally annually.

The market is growing significantly due to a number of factors, including increased awareness of parasitic diseases, improvements in drug development technologies, the growing demand for animal healthcare products, government initiatives to control parasitic diseases, especially in developed nations, increased investment in research and development, expanding healthcare infrastructure, and rising levels of disposable income. One of the most significant issues in places like North America is human health. The market is expanding due to the rising need for antiparasitic medications to treat a number of infectious disorders.

Segmentation

By Application

·         Animal Health

·         Human Health

·         Crop Health

By Route of Administration

·         Oral

·         Injectable

·         Topical

By Product Type

·         Anthelmintic

·         Antiprotozoal Agents

·         Ectoparasitic ides

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Key Players

·         GlaxoSmithKline Plc

·         Dr. Reddy’s Laboratories Ltd

·         Cipla Limited

·         Pfizer Inc

·         AstraZeneca

·         Glenmark Pharmaceuticals Ltd

·         Novartis AG

·         Sun Pharmaceuticals Pvt. Ltd

·         Aurobindo Pharma

·         Vivaldis

·         Advacare Pharma

·         Cadila Pharmaceuticals

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/antiparasitic-drugs-market

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/